NM

Nanjundappa Mallikarajuna

Active Director Director DIN 11144559
DIN 11144559 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nanjundappa Mallikarajuna

Data last updated:

Nanjundappa Mallikarajuna is a Director at Sindoor Healthtech Private Limited (since 2025). The company operates in Pharma.

DIN 11144559
Primary Designation Director
Industry Pharma
First Appointment 07 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sindoor Healthtech Private Limited U21009KA2025PTC203851
Director07 Jun 20252025Active

Directorship timeline

Open interactive timeline →
Sindoor Healthtech Private Limited
Premium access

Shareholding and investment profile for Nanjundappa Mallikarajuna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanjundappa Mallikarajuna

Nanjundappa Mallikarajuna currently holds 1 directorship: Sindoor Healthtech Private Limited (Director, since 07 Jun 2025).

Nanjundappa Mallikarajuna was first appointed on 07 Jun 2025 as Director at Sindoor Healthtech Private Limited.

The current boards of Nanjundappa Mallikarajuna's companies include Chandrakant Chinchapur Nitin (Sindoor Healthtech Private Limited), Gangadhar Ajay (Sindoor Healthtech Private Limited), Kumar Chilur Balaiah Arun (Sindoor Healthtech Private Limited), Vinay Mohan Haritsa (Sindoor Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available